# Cayman Chemical Company, Inc. – FDA Inspection, May 18, 2009

Source: https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/72b6dea6-76be-4221-83d1-586b8511c118
Source feed: FDA_Inspections

> FDA inspection 583096 of Cayman Chemical Company, Inc., May 18, 2009. Classification: Official Action Indicated (OAI). 14 citations under 21 CFR parts 50 and 312. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 583096
- Company Name: Cayman Chemical Company, Inc.
- Inspection Date: 2009-05-18
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 14

## Related Documents

- [FDA Inspection 1267154 - 2025-04-17](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/50014726-fa53-47de-878c-6e8551c827ff)
- [FDA Inspection 1074100 - 2018-12-03](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/3453ef33-da57-46f9-b6c1-2c6519ccd350)
- FDA Inspection 904339 - 2014-11-19
- FDA Inspection 820205 - 2013-02-28
- FDA Inspection 759917 - 2011-12-22

Company: https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c